article · Blood Pressure
The NHANES mortality outcomes support the use of eGFR<sub>cys</sub> and eGFR<sub>cr-cys</sub>. However, large intraindividual variability between eGFR estimates may lead to KDIGO eGFR stage misclassification and calls for caution in the opportunistic or systematic screening for CKD in asymptomatic individuals with prevention as objective.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1080/08037051.2025.2533456
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
